<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046689</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Is migraine a progressive cerebral disease?</dc:title>
<dc:description xml:lang="en">Migraine is a primary neurovascular headache which affects approximately 12% of the adult population. Migraine particularly affects women of working age and is associated with significant disability and reduced quality of life. During migraine attacks, the capacity to engage in daily activities such as child care, work, and social activities is reduced, and relationships with family members and friends become strained. In this respect, migraine places a heavy economic burden on both the individual and society. It is also known migraine is a risk factor for ischemic stroke in young women with migraine with aura. Recently, it was reported that some individuals that experience migraine with and without aura may be at an        increased risk for subclinical lesions in certain areas of the brain. Cerebral white matter lesions (WMLs) are a common finding on cerebral MRI scans. Although, it appears that cerebral WMLs are more common in migraineurs than in the general population, the nature, association and the clinical significance of cerebral WMLs in migraineurs are not yet conclusive. Furthermore, there is no good evidence to support the notion that cerebral WMLs in migraineurs can predict subclinical or clinical stroke in these individuals. Needless to say, the need for more longitudinal and prospective migraine research is immense. The aim of the future migraine research should be to obtain more information about the natural course of migraine as well as evaluate the association between migraine and cerebral WMLs and their consequences. In addition, continuing genetic identification of key proteins involved in migraine will improve our understanding of this common and sometimes most debilitating disorder, which can strike during the most productive years of a person's life</dc:description>
<dc:creator>Lainez, J. M</dc:creator>
<dc:creator>Pascual, J</dc:creator>
<dc:creator>Linton-Dahlöf, P</dc:creator>
<dc:creator>Dahlöf, C. G. H</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La migraña es una cefalea de origen neurovascular sufrida por aproximadamente el 12 % de la población adulta. La migraña afecta particularmente a mujeres en edad laboral y condiciona una considerable carga económica tanto para el individuo que la padece como para la sociedad. El sufrimiento psicosocial y humano, tanto del individuo afectado como de su familia, como consecuencia de la migraña, es de una gran dimensión. Se ha demostrado que la migraña es un factor de riesgo para la isquemia cerebral en mujeres jóvenes y recientemente se ha establecido que aquellos individuos que sufren migraña con y sin aura tienen un mayor riesgo de presentar lesiones subclínicas en ciertas áreas del cerebro. Sin embargo, la asociación, naturaleza y la trascendencia clínica de las lesiones de la sustancia blanca (LSB) en enfermos de migraña no son todavía concluyentes y no hay pruebas definitivas que respalden la noción de que las LSB cerebrales en enfermos de migraña puedan pronosticar isquemia cerebral subclínica o clínica en estos individuos. Por tanto, es absolutamente necesaria una investigación longitudinal y prospectiva en la migraña. Esta futura investigación debe hacer un esfuerzo especial por obtener más información sobre el curso natural de la enfermedad y evaluar la asociación entre la migraña y LSB cerebrales y sus consecuencias. Además, la futura identificación genética de proteínas clave involucradas en la migraña mejorará nuestro conocimiento sobre esta enfermedad tan común y debilitante</dc:description>
<dc:source>Neurologia;20(7): 356-365, sept. 2005.</dc:source>
<dc:identifier>ibc-046689</dc:identifier>
<dc:title xml:lang="es">¿La migraña es una enfermedad cerebral progresiva?</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2579^s22004</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1953^s22032</dc:subject>
<dc:subject>^d1953^s22053</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d212</dc:subject>
<dc:subject>^d2579^s22053</dc:subject>
<dc:subject>^d2579^s22031</dc:subject>
<dc:subject>^d9068^s22053</dc:subject>
<dc:subject>^d9068^s22032</dc:subject>
<dc:subject>^d34247^s22032</dc:subject>
<dc:subject>^d3103^s22032</dc:subject>
<dc:subject>^d34247^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200509</dc:date>
</metadata>
</record>
</ibecs-document>
